Sector ratings Natera, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:16:20 08/06/2026 BST			5-day change	1st Jan Change
216.61 ^USD	+0.60%		-1.09%	-5.53%

06-04	Natera and CytoDyn Announces Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer	CI
06-03	Natera Appoints Drs. Thomas Lynch and Eric Rubin to Board of Directors	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NATERA, INC.	30.84B	-	BB	-		-
LABCORP HOLDINGS INC.	21.74B		AA
SONIC HEALTHCARE LIMITED	6.76B		AA
RADNET, INC.	4.27B	-	A	-		-
DR. LAL PATHLABS LIMITED	2.7B		A
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	1.64B		AA
FLEURY S.A.	1.56B		AA
GENEDX HOLDINGS CORP.	1.55B	-	BBB	-		-
DIAN DIAGNOSTICS GROUP CO.,LTD.	1.52B		-
VIJAYA DIAGNOSTIC CENTRE LIMITED	1.48B		-
NEOGENOMICS, INC.	1.42B	-	AA	-		-
H.U. GROUP HOLDINGS, INC.	1.16B		AAA
OPKO HEALTH, INC.	1.09B	-	BBB	-		-
THYROCARE TECHNOLOGIES LIMITED	862M	-	-	-		-
BML, INC.	837M	-	AA	-		-	-
NOVOGENE CO., LTD.	807M		-			-
INTEGRAL DIAGNOSTICS LIMITED	545M		AA
FULGENT GENETICS, INC.	544M	-	AA	-		-	-
ARTRYA LIMITED	541M	-	-	-		-
SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD	520M	-	-	-	-	-	-	-
Average	4.12B		AA
Weighted average by Cap.			AA